Clinical Trials Directory

Trials / Completed

CompletedNCT01450202

Safety and Efficacy of Carbon Dioxide Insufflation During Colonoscopy With Consecutive Esophagogastroduodenoscopy in Reduction of Abdominal Pain in Sedated Outpatients

Carbon Dioxide Insufflation During Colonoscopy With Consecutive EGD is Safe and Decreases Abdominal Pain in Sedated Outpatients: a Randomized, Double-blind, Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Inje University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Compared with performing each procedure individually, performing two combined procedures such as colonoscopy consecutive Esophagogastroduodenoscopy (EGD) cause more bowel gases, abdominal distension and post-procedure pain because of longer procedure time related to more bowel insufflated gas than one procedure. To the best of the investigators knowledge, there has been no randomized controlled trial of CO2 versus air for insufflations during combined two procedures, colonoscopy with consecutive EGD. And there are a few well randomized trials concerned CO2 insufflation in patients receiving sedation during colonoscopy. The aim of the present study was to evaluate the efficacy of CO2 in reducing post-procedural abdominal pain and distension during colonoscopy consecutive EGD and to confirm the safety of CO2 insufflation when it is used during procedure in sedated outpatients.

Conditions

Interventions

TypeNameDescription
OTHERbowel insufflation gasair insufflation, during colonoscopy and esophagogastroduodenoscopy
OTHERbowel insufflation gasCO2 insufflation, during colonoscopy and esophagogastroduodenoscopy

Timeline

Start date
2011-11-01
Primary completion
2011-12-01
Completion
2012-01-01
First posted
2011-10-12
Last updated
2012-06-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01450202. Inclusion in this directory is not an endorsement.